Consultation on the new Manual of Patent Office Practice Chapter 17 section on medical kits

This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

The Canadian Intellectual Property Office (CIPO) is conducting a three-week consultation on a proposed new section of chapter 17 of the Manual of Patent Office Practice (MOPOP) dealing with medical kits.

From now to May 15, 2017, the Canadian Intellectual Property Office (CIPO) will be conducting a consultation on proposed changes to the Manual of Patent Office Practice (MOPOP). We are seeking feedback on proposed changes to chapter 17 relating to medical kits.

The proposed changes will lead to additional certainty and consistency in the patent examination process. The proposed update to chapter 17 relating to medical kits will be a new section to address a guidance gap in the MOPOP.


April 24th to May 15th, 2017


MOPOP Chapter 17 deals with various topics relating to the examination of patent applications in the fields of biotechnology and medicinal inventions. The proposed section of chapter 17 introduces a new topic of medical kits. The proposed section will bring consistency and clarity to the examination of medical kits.

The MOPOP is published to provide patent examiners, applicants, agents, and the public in general with a guide on the procedures and practices relative to the prosecution of patent applications in Canada under the current Patent Act and Patent Rules. This Manual is to be considered solely as a guide and should not be quoted as an authority. Authority must be found in the Patent Act, the Patent Rules and decisions of the Courts interpreting them.

Consultation document

Chapter 17: Kits and packages

Consultation comments received


Any business, individual, group or organization that has an interest in the examination of patent applications in Canada.


CIPO values your views and would like to hear about how the proposed chapters align with the Patent Act, Patent Rules and current jurisprudence. Please share with us your comments and feedback by sending an email to: Please include "MOPOP chapter 17 consultation" in the subject line.


Should you have any questions about this consultation, please send them by email to Josée Pharand or by regular mail to the following address:

Canadian Intellectual Property Office
Patent Branch
50 Victoria Street
Place du Portage I
Gatineau, QC
K1A 0C9
Attention: Josée Pharand